Targeting the EGFR signaling pathway in cancer therapy

Por Seshacharyulu, Parthasarathy, Ponnusamy, Moorthy P., Haridas, Dhanya, Jain, Maneesh, Ganti, AparK., Batra, Surinder K.
Publicado em 2012

Immunocytochemistry for MUC4 and MUC16 Is a Useful Adjunct in the Diagnosis of Pancreatic Adenocarcinoma on Fine-Needle Aspiration Cytology

Por Horn, Adam, Chakraborty, Subhankar, Dey, Parama, Haridas, Dhanya, Souchek, Joshua, Batra, Surinder K., Lele, Subodh M.
Publicado em 2013

Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer

Por Rachagani, Satyanarayana, Macha, Muzafar A., Heimann, Nicholas, Seshacharyulu, Parthasarathy, Haridas, Dhanya, Chugh, Seema, Batra, Surinder K.
Publicado no Adv Drug Deliv Rev (2014)

MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1

Por Rachagani, Satyanarayana, Macha, Muzafar A, Ponnusamy, Moorthy P., Haridas, Dhanya, Kaur, Sukhwinder, Jain, Maneesh, Batra, Surinder K
Publicado em 2012

Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer

Por Seshacharyulu, Parthasarathy, Ponnusamy, Moorthy P., Rachagani, Satyanarayana, Lakshmanan, Imayavaramban, Haridas, Dhanya, Yan, Ying, Ganti, Apar K., Batra, Surinder K.
Publicado no Oncotarget (2014)

MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism

Por Muniyan, Sakthivel, Haridas, Dhanya, Chugh, Seema, Rachagani, Satyanarayana, Lakshmanan, Imayavaramban, Gupta, Suprit, Seshacharyulu, Parthasarathy, Smith, Lynette M., Ponnusamy, Moorthy P., Batra, Surinder K.
Publicado no Genes Cancer (2016)

Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells

Por Lakshmanan, Imayavaramban, Seshacharyulu, Parthasarathy, Haridas, Dhanya, Rachagani, Satyanarayana, Gupta, Suprit, Joshi, Suhasini, Guda, Chittibabu, Yan, Ying, Jain, Maneesh, Ganti, Apar K., Ponnusamy, Moorthy P., Batra, Surinder K.
Publicado no Oncotarget (2015)

MUC16-mediated activation of mTOR and c-MYC reprograms pancreatic cancer metabolism

Por Shukla, Surendra K., Gunda, Venugopal, Abrego, Jaime, Haridas, Dhanya, Mishra, Anusha, Souchek, Joshua, Chaika, Nina V., Yu, Fang, Sasson, Aaron R., Lazenby, Audrey J., Batra, Surinder K., Singh, Pankaj K.
Publicado no Oncotarget (2015)

Pathobiological Implications of MUC16 Expression in Pancreatic Cancer

Por Haridas, Dhanya, Chakraborty, Subhankar, Ponnusamy, Moorthy P., Lakshmanan, Imayavaramban, Rachagani, Satyanarayana, Cruz, Eric, Kumar, Sushil, Das, Srustidhar, Lele, Subodh M., Anderson, Judy M., Wittel, Uwe A., Hollingsworth, Michael A., Batra, Surinder K.
Publicado em 2011

Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy

Por Rachagani, Satyanarayana, Torres, María P, Kumar, Sushil, Haridas, Dhanya, Baine, Michael, Macha, Muzafar A, Kaur, Sukhwinder, Ponnusamy, Moorthy P, Dey, Parama, Seshacharyulu, Parthasarathy, Johansson, Sonny L, Jain, Maneesh, Wagner, Kay-Uwe, Batra, Surinder K
Publicado em 2012

Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis

Por Pandey, Poomy, Rachagani, Satyanarayana, Das, Srustidhar, Seshacharyulu, Parthasarathy, Sheinin, Yuri, Naslavsky, Naava, Pan, Zenggang, Smith, Brittney L., Peters, Haley L., Radhakrishnan, Prakash, McKenna, Nicole R., Giridharan, Sai Srinivas Panapakkam, Haridas, Dhanya, Kaur, Sukhwinder, Hollingsworth, Michael A., MacDonald, Richard G., Meza, Jane L., Caplan, Steve, Batra, Surinder K., Solheim, Joyce C.
Publicado no Oncotarget (2014)